Non-opioid pain Target health systems and pain clinics focused on non-opioid therapies to align with Neuralace Medical's Axon Therapy and its case reports for chronic low back pain, highlighting a fit for physicians seeking alternatives to conventional management.

Non-invasive niche Emphasize sales opportunities with hospitals and clinics seeking non-invasive neuromodulation options, positioning Axon Therapy as a differentiator in chronic pain treatment with minimal side effects.

Growth potential Leverage the company’s small-to-mid-size profile (11-50 employees) and recent milestones to pitch pilots, early adoption programs, and strategic partnerships that can scale as Neuralace expands.

Evidence-backed Highlight opportunities to leverage the ASPN conference case report and ongoing clinical evidence to support reimbursement dialogues, clinician education, and outcomes-based selling with payers.

Funding signals Note the historical funding and leadership changes to approach venture-backed research institutions, university-affiliated pain programs, and accelerators as potential collaboration or investment-led distribution channels.